Mutant KRAS is a druggable target for pancreatic cancer

作者: E. Zorde Khvalevsky , R. Gabai , I. H. Rachmut , E. Horwitz , Z. Brunschwig

DOI: 10.1073/PNAS.1314307110

关键词: Cancer researchPancreatic cancerIn vivoKRASOncogeneImmunologyGene silencingTargeted therapySiG12D LODERGenetic enhancementBiology

摘要: … and prolonged delivery of siRNA. Our results show that the siRNA targeted against KRAS mutations with a local prolonged release system knocks down KRAS expression in vitro and in …

参考文章(21)
Yannick Delpu, Naima Hanoun, Hubert Lulka, Flavie Sicard, Janick Selves, Louis Buscail, Jerome Torrisani, Pierre Cordelier, Genetic and epigenetic alterations in pancreatic carcinogenesis. Current Genomics. ,vol. 12, pp. 15- 24 ,(2011) , 10.2174/138920211794520132
Cristóbal Belda-Iniesta, Inmaculada Ibáñez de Cáceres, Jorge Barriuso, Javier de Castro Carpeño, Manuel González Barón, Jaime Feliú, Molecular biology of pancreatic cancer Clinical & Translational Oncology. ,vol. 10, pp. 530- 537 ,(2008) , 10.1007/S12094-008-0247-6
Sorin E. Leucuta, Drug delivery systems with modified release for systemic and biophase bioavailability. Current Clinical Pharmacology. ,vol. 7, pp. 282- 317 ,(2012) , 10.2174/157488412803305786
Bret B. Friday, Alex A. Adjei, K-ras as a target for cancer therapy. Biochimica et Biophysica Acta. ,vol. 1756, pp. 127- 144 ,(2005) , 10.1016/J.BBCAN.2005.08.001
Georg Feldmann, Robert Beaty, Ralph H. Hruban, Anirban Maitra, Molecular genetics of pancreatic intraepithelial neoplasia. Journal of Hepato-biliary-pancreatic Surgery. ,vol. 14, pp. 224- 232 ,(2007) , 10.1007/S00534-006-1166-5
C Sun, T Yamato, T Furukawa, Y Ohnishi, H Kijima, A Horii, Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines. Oncology Reports. ,vol. 8, pp. 89- 92 ,(2001) , 10.3892/OR.8.1.89
Naama Klopstock, Carol Levy, Devorah Olam, Eithan Galun, Daniel Goldenberg, Testing transgenic regulatory elements through live mouse imaging FEBS Letters. ,vol. 581, pp. 3986- 3990 ,(2007) , 10.1016/J.FEBSLET.2007.07.029
Nima Khadem Mohtaram, Amy Montgomery, Stephanie M Willerth, Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors. Biomedical Materials. ,vol. 8, pp. 022001- ,(2013) , 10.1088/1748-6041/8/2/022001
David Hudson, Argyrios Margaritis, Biopolymer nanoparticle production for controlled release of biopharmaceuticals. Critical Reviews in Biotechnology. ,vol. 34, pp. 161- 179 ,(2014) , 10.3109/07388551.2012.743503